Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer

Lead

Institute of Cancer Research, United Kingdom

With

• Prostate Cancer UK
• Janssen Pharmaceutica N.V., Belgium
• Oncology Institute of Southern Switzerland
• Syntrix Biosystems, Inc.
• Royal Marsden NHS Foundation Trust
• Cambridge University Hospitals NHS Foundation Trust
• Belfast Health and Social Care Trust
• Institute of Oncology Research (IOR)